| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |